📊 Full opportunity report: Vertigo relief app on IdeaNavigator AI — validation score, market gap, and execution plan.
TL;DR
A new vertigo relief app is being developed to help adults with BPPV perform repositioning maneuvers at home. It combines motion sensors, guided instructions, and symptom tracking, aiming to improve self-treatment and reduce relapse rates. The app is targeting both consumers and clinics, with validation underway.
A new vertigo relief mobile app is in development to assist adults suffering from benign paroxysmal positional vertigo (BPPV) in performing repositioning maneuvers correctly at home, potentially reducing the need for frequent clinic visits. The app incorporates motion sensors, guided step-by-step instructions, and symptom logging, aiming to improve self-treatment outcomes for patients and support ENT clinics and physiotherapists in managing recurrent vertigo episodes.
The app is designed for iOS and Android devices and targets adults, predominantly women and older individuals, who experience recurrent BPPV. It begins with a simple screening survey and optional motion-sensor self-check to assess candidacy. Users are then guided through the Epley and Brandt-Daroff maneuvers with animated visuals, audio cues, and real-time gyroscope feedback to ensure correct head positioning.
In addition to guiding users through maneuvers, the app logs dizziness episodes, triggers, and symptom severity over time. It features a freemium model, offering basic maneuver guidance for free and charging for advanced features such as detailed symptom tracking, history export, and reminders. A separate B2B version is planned for clinics to license the platform for patient home care, integrating digital therapeutics into existing treatment workflows.
The market opportunity is driven by increased telehealth adoption, smartphone sensor capabilities, and growing acceptance of digital therapeutics for vestibular disorders. The digital vestibular rehabilitation market was valued at approximately USD 498 million in 2024, with a projected annual growth rate of about 13.5% through 2033, according to industry estimates.
Potential Impact on BPPV Self-Management
This app could significantly improve the quality of life for BPPV patients by enabling effective self-treatment at home, reducing relapse rates, and decreasing wait times for specialist care. It also offers a scalable solution for clinics to support ongoing patient management remotely, aligning with the broader shift toward telehealth and digital health solutions.
By providing guided, sensor-enabled repositioning, the app aims to reduce incorrect self-treatment, which is common due to static diagrams and lack of real-time feedback. If validated, it could become a standard tool in vestibular care, complementing in-person therapy and reducing the burden on healthcare systems.
vestibular rehabilitation motion sensors
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Growing Demand for Digital Vertigo Solutions
Benign paroxysmal positional vertigo (BPPV) is the most common vestibular disorder, with recurrence occurring in roughly half of cases. Traditionally, treatment involves manual repositioning maneuvers performed by clinicians, but many patients face long waits for specialist appointments and struggle to perform these maneuvers correctly at home.
The COVID-19 pandemic accelerated telehealth adoption, prompting a shift toward remote management of vestibular disorders. Smartphones now include highly accurate gyroscope sensors capable of measuring head angles, enabling real-time feedback for self-administered therapies. Industry estimates place the digital vestibular rehabilitation market near USD 498 million in 2024, with strong growth expected as payer acceptance and clinician adoption increase.
Previous efforts to develop digital therapeutics for vertigo have been limited, often relying on static instructions or basic video guidance. This new app aims to leverage sensor technology and guided instructions to improve efficacy and user engagement, addressing a significant unmet need in the market.
“Integrating motion sensors with guided maneuvers could revolutionize how patients manage BPPV at home, reducing relapse and improving outcomes.”
— an anonymous researcher
BPPV repositioning maneuver app
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Unconfirmed Aspects of App Validation and Adoption
It is not yet clear how effectively the app will perform in real-world settings or how quickly clinics and patients will adopt it. Validation studies are still in planning stages, and user engagement metrics remain to be seen. The regulatory pathway and reimbursement models for digital therapeutics in this space are also evolving, which could influence rollout timelines.
vertigo symptom tracking device
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Next Steps for Testing and Market Integration
Developers plan to launch a lightweight landing page with a guided Epley maneuver demo and run targeted advertising campaigns to assess interest and collect user signups. They will also pitch ENT and physiotherapy clinics to pilot the app with patients, measuring clinical interest and potential integration into treatment workflows. Validation studies and regulatory considerations will shape the product’s subsequent development and deployment phases.
digital vestibular therapy tools
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Key Questions
How does the app guide users through maneuvers?
The app uses animated visuals, audio cues, and gyroscope-based feedback to ensure correct head positioning during repositioning maneuvers like the Epley and Brandt-Daroff.
Can this app replace in-person treatment?
No. The app is designed as a supplementary tool to assist self-management and support clinical care, not as a substitute for professional medical advice.
Will clinics be able to license the app for their patients?
Yes. A B2B licensing model is planned, allowing ENT clinics, audiologists, and physiotherapists to recommend or white-label the app for use between visits.
What features will be available in the premium version?
Premium features include detailed symptom tracking, history export, reminders, and personalized recurrence coaching, all aimed at improving long-term management.
When will the app be available for general use?
The development and validation phases are ongoing, with initial testing phases expected within the next few months. A broader release will depend on validation outcomes and regulatory approval.
Source: IdeaNavigator AI
